134 Grants (Page 5 of 6)
1997
ANTIVIRAL ACTIVITY AND RESISTANCE OF LAMIVUDINE IN COMBINATION WITH DDI OR D4T
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0533), 03/13/1997 -- 11/30/1997
 
D4T VS ZDV PLUS A4T VS ZDV PLUS DDI IN HIV INFECTED PATIENTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0509), 03/13/1997 -- 11/30/1997
 
INFLUENCE OF RISK FOR DISEASE PROGRESSION ON RESPONSE TO ANTIRETROVIRAL THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0529), 03/13/1997 -- 11/30/1997
 
MULTIDRUG COMBINATION ANTIRETROVIRAL THERAPY FOR HIV
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0502), 03/13/1997 -- 11/30/1997
 
NUCLEOSIDE THERAPY FOR ADVANCED HIV DISEASE WITH PRIOR NUCLEOSIDE THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0396), 03/13/1997 -- 11/30/1997
 
OPEN LABEL TREATMENT OF HIV INFECTED SUBJECT WITH TIMUNOX
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0527), 03/13/1997 -- 11/30/1997
 
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0289), 03/13/1997 -- 11/30/1997
 
RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF INDINAVIR SULFATE (IDV)
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0545), 03/13/1997 -- 11/30/1997
 
TIMUNOX IN ASYMPTOMATIC HIV PATIENTS W/MONO OR COMBO ANTIRETROVIRAL THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-25-0425), 03/13/1997 -- 11/30/1997
1996
256U87 COMPARED TO ACYCLOVIR FOR SUPPRESSION OF ANOGENITAL HERPES FOR HIV
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0403), 1996
 
ANTIRETROVIRAL THERAPIES ON VIRAL BURDEN IN EARLY HIV1 INFECTION
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0510), 1996
 
BW 256U87 PROPHYLAXIS FOR OPPORTUNISTIC CYTOMEGALOVIRUS END ORGAN DISEASE IN HIV
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0394), 1996
 
D4T VS ZDV PLUS A4T VS ZDV PLUS DDI IN HIV INFECTED PATIENTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0509), 1996
 
MONOTHERAPY VS COMBINATION THERAPY WITH NUCLEOSIDE ANALOGUES IN HIV INFECTION
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0359), 1996
 
MULTIDRUG COMBINATION ANTIRETROVIRAL THERAPY FOR HIV
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0502), 1996
 
NUCLEOSIDE THERAPY FOR ADVANCED HIV DISEASE WITH PRIOR NUCLEOSIDE THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0396), 1996
 
PHASE II DOUBLE BLIND STUDY OF 2 DOSES OF SC-49483 IN COMBINATION WITH ZDV
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0460), 1996
 
TIMUNOX IN ASYMPTOMATIC HIV PATIENTS W/MONO OR COMBO ANTIRETROVIRAL THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-24-0425), 1996
1995
256U87 COMPARED TO ACYCLOVIR FOR SUPPRESSION OF ANO-GENITAL HERPES FOR HIV
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-23-0403), 1995
 
AIDS-ASSOCIATED KAPOSI'S SARCOMA--MAX TOLERATED DOSE OF R-METHUFIN &INTRON-A
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-23-0335), 1995
 
BW 256U87 PROPHYLAXIS FOR OPPORTUNISTIC CYTOMEGALOVIRUS END-ORGAN DISEASE IN HIV
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-23-0394), 1995
 
COMPARISON OF 256U87 VS ACYCLOVIR IN RECURRENT HERPES INFECTION IN AIDS PATIENTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-23-0385), 1995
 
ISIS 2105 W/VEHICLE CONTROL FOR SURGICAL ADJUNCTIVE THERAPY/CONDYLOMA ACUMINATUM
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-23-0402), 1995
 
LOW DOSE VS STANDARD DOSE MBACOD CHEMOTHERAPY WITH RGM-CSF FOR AIDS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-23-0433), 1995
 
LY300046 HCL--SAFETY AND PHARMACOKINETICS IN HIV-INFECTED SUBJECTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-23-0415), 1995